Manipal Health Enterprises Limited IPO
LISTEDMAINBOARDNEUTRALMANIPALHOSListing Performance
Listed
Issue Price
₹590
Listed On
05 Aug 2026
- Price Band
- ₹560 – ₹590
- Lot Size
- 25
- Lot Value
- ₹14,750
- Open Date
- 29 Jul29 Jul 2026
- Close Date
- 31 Jul31 Jul 2026
- Min Investment
- ₹14,750
About Manipal Health Enterprises Limited
Manipal Health Enterprises Limited is a healthcare service provider engaged in running and managing hospitals, clinics and diagnostic centres, primarily in India. It operates a network of multi-speciality hospitals offering clinical services across several specialities, with a focus on tertiary and quaternary care such as cardiac sciences, oncology, neurosciences, gastro sciences, orthopaedics and renal sciences. The company serves patients through inpatient and outpatient services, generating revenue from healthcare services paid by patients directly, insurance and third-party administrators, government schemes and corporate arrangements. Its network includes multiple hospitals supported by a large pool of doctors, and it caters to a significant volume of patients across its facilities. The company operates as a single business segment focused on medical and healthcare services, combining hospital infrastructure, clinical expertise and diagnostic capabilities to deliver care. Read more Discuss on Trading Q&A
Investment Analysis
Quick Analysis: 5 strengths · 5 risk factors· Exchange: NSE
Strengths (5)
- •A large network of multi-speciality hospitals supported by a wide base of doctors.
- •Focus on high-end specialities like cardiac, oncology and neurosciences, driving revenue.
- •Strong presence across key regions with ongoing expansion plans.
- •Significant share of revenue from insurance and institutional payors.
- •Established track record of growth in patient volumes and operations.
Risk Factors (5)
- •High dependence on insurance and third-party administrators for revenue.
- •Delays in payments from government schemes can impact cash flows.
- •Expansion into new regions may face operational and market challenges.
- •Failure to attract sufficient patients can lead to underutilised capacity.
- •High outstanding receivables may affect working capital and liquidity.
📊 Algorithmic Score
Computed from issue structure — GMP, fresh issue %, OFS %, issue size
Why do these differ? The Algorithmic Score measures issue quality (structure, size, promoter commitment). The Demand Analysis measures investor interest signals (subscription, GMP, risks). A high-quality issue can still have unconfirmed demand — especially before subscription opens.
✍️ Demand & Risk Analysis
Based on market demand signals — subscription, GMP trend, risk factors
IPO Market Analysis
“Mixed signals — moderate demand and average GMP suggest cautious participation. Apply based on company fundamentals rather than listing gain expectations.”
- ✅Subscribed 5x
- ✅Strong QIB demand 8x
- ⚠️Negative GMP -3%
- ✅5 business strengths identified
- ⚠️5 risk factors noted
- ✅Mainboard IPO (higher regulatory standards)
This is algorithmic analysis, not investment advice. Always read the DRHP before investing.
Application Lot Sizes
Retail caps at ₹2,00,000 (13 lots here). S-HNI is ₹2L–₹10L, B-HNI is above ₹10L.
| Category | Lots | Shares | Amount |
|---|---|---|---|
| Retail (min) | 1 | 25 | ₹14,750 |
| Retail (max) | 13 | 325 | ₹1,91,750 |
| S-HNI (min) | 14 | 350 | ₹2,06,500 |
| S-HNI (max) | 67 | 1,675 | ₹9,88,250 |
| B-HNI (min) | 68 | 1,700 | ₹10,03,000 |
Subscription Status
| Category | Day 1 | Day 2 | Day 3 |
|---|---|---|---|
| QIB | 0.14x | 0.60x | 8.25x |
| sNII (S-HNI) | — | — | — |
| bNII (B-HNI) | — | — | — |
| Retail | 0.25x | 0.45x | 0.92x |
| Total | 0.14x | 0.45x | 4.92x |
Colour: red <1x · amber 1–10x · green ≥10x oversubscribed.
Allotment Statistics
Retail Individual Investors (RII)
Subscription
0.92x
Allotment Ratio
Full allotment
Allotment Probability
~100.0%
Non-Institutional Investors (NII / HNI)
Subscription
1.01x
Allotment Type
Proportionate allotment
Qualified Institutional Buyers (QIB)
Subscription
8.25x
Allotment Type
Discretionary allotment
Total Subscription
4.92x
Allotment probability is estimated based on subscription data and is not guaranteed. Actual allotment depends on the registrar's process.
Basis of Allotment
Category-wise subscription & allotment ratio
Weigh your chances
IPO Timeline
Issue Opens
29 Jul 2026 · Wed
Issue Closes
31 Jul 2026 · Fri
UPI Deadline
31 Jul 2026 · Fri
Allotment
03 Aug 2026 · Mon
Refund
04 Aug 2026 · Tue
Share Credit
04 Aug 2026 · Tue
Listing
05 Aug 2026 · Wed
Issue Opens
29 Jul 2026 · Wed
Issue Closes
31 Jul 2026 · Fri
UPI Deadline
31 Jul 2026 · Fri
Allotment
03 Aug 2026 · Mon
Refund
04 Aug 2026 · Tue
Share Credit
04 Aug 2026 · Tue
Listing
05 Aug 2026 · Wed
IPO Details
| Registrar | KFin Technologies Limited |
| Exchange | NSE |
| ISIN | — |
| Face Value | ₹2 |
| Issue Size | ₹9275.00 Cr |
| Fresh Issue | — |
| OFS Size | — |
| Lead Managers | — |
3-Year Financial Summary
Financial data not available yet.
Check the valuation yourself
Company Fundamentals
Capital Structure
Capital structure not yet available.
Shareholding Pattern
Shareholding pattern not yet available.
Reservations & OFS
Reservation & OFS detail not yet available.
Board & Management
Board & management not yet available.
Industry & Market
Industry & market data not yet available.
Registrar (RTA)
SEBI-registered Registrar & Transfer Agent — handles allotment and refunds.
Registrar:KFin Technologies Limited→Documents
Frequently Asked Questions
When is the Manipal Health Enterprises Limited IPO opening?
The Manipal Health Enterprises Limited IPO opens on 29 Jul 2026 and closes on 31 Jul 2026. Check this page for the latest updates as we refresh every 30 minutes.
What is the price band of the Manipal Health Enterprises Limited IPO?
The price band for the Manipal Health Enterprises Limited IPO is ₹560 to ₹590. The final price is announced after the book-building process and is confirmed before listing.
What is the lot size and minimum investment for the Manipal Health Enterprises Limited IPO?
The minimum lot size is 25 shares with a minimum investment of ₹14,750. Retail investors can apply for up to the retail limit defined by SEBI.
What is the GMP of Manipal Health Enterprises Limited IPO today?
The latest Grey Market Premium for Manipal Health Enterprises Limited is ₹-15 (-2.50%). GMP is unofficial data and is not a guarantee of listing price.
When will the Manipal Health Enterprises Limited IPO list on NSE and BSE?
The Manipal Health Enterprises Limited IPO is expected to list on 05 Aug 2026 on NSE. Actual listing day trading begins at the start of the normal market session.
How can I check the Manipal Health Enterprises Limited IPO allotment status?
The registrar for this IPO is KFin Technologies Limited. You can check your allotment status on the registrar's portal using your PAN, application number, or DP ID. We link to the registrar directly on our allotment page after the allotment date.
Is the Manipal Health Enterprises Limited IPO a mainboard or SME issue?
Manipal Health Enterprises Limited is a mainboard IPO that will list on the main NSE and BSE boards. Mainboard IPOs are open to retail investors with a minimum application of one lot.
How do I apply for the Manipal Health Enterprises Limited IPO?
You can apply for the Manipal Health Enterprises Limited IPO through any SEBI-registered broker such as Zerodha, Upstox, or Angel One using UPI or ASBA. Use the Apply Now buttons on this page to go directly to the broker.
What is the expected listing price of Manipal Health Enterprises Limited IPO?
Based on the current GMP of ₹-15, the expected listing price of Manipal Health Enterprises Limited is ₹575 (issue price ₹590 + GMP ₹-15). Note that GMP is unofficial grey market data and actual listing price may differ.
What is the allotment ratio for Manipal Health Enterprises Limited IPO?
Based on the retail subscription of 0.92x, all retail applicants are expected to receive full allotment for the Manipal Health Enterprises Limited IPO.
Should I subscribe to Manipal Health Enterprises Limited IPO?
Based on our algorithmic analysis, Manipal Health Enterprises Limited IPO is rated NEUTRAL with high confidence. Mixed signals — moderate demand and average GMP suggest cautious participation. Apply based on company fundamentals rather than listing gain expectations. This is not investment advice — please read the DRHP and consult a financial advisor before investing.
Recently Listed IPOs
| Company | Listed | Listing Gain |
|---|---|---|
| Veegaland Developers | 18 Sep 2026 | +10.00% |
| Steamhouse India | 17 Sep 2026 | +16.67% |
| Manipal Payment & Identity Solutions | 17 Sep 2026 | -2.65% |
Related IPOs
Related Articles
How to Compare an IPO With Listed Peers Using Key Ratios and Growth Metrics
A practical framework for Indian retail investors on comparing an IPO with its listed peers using P/E, P/B, EV/EBITDA and growth metrics, illustrated with the NSE vs BSE case study.
Read more →
How-ToMultiple IPO Apps Won't Boost Your Allotment: The PAN Rule Explained
Many retail investors think using PhonePe, BHIM and their broker app for the same IPO creates multiple chances. It doesn't. Here is how SEBI's PAN rule actually works and the only legitimate way to improve household allotment odds.
Read more →
How-ToHow to Analyse an Indian IPO in Under 60 Minutes: A Retail Investor's Checklist
A practical, DRHP-first framework retail investors can use to size up an Indian IPO quickly, covering financials, valuation, peer comparison, use of proceeds and risk factors.
Read more →